arrow
A

Allyson L. Varley

University of Alabama Birmingham
H指数:18
被引数:787

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Data of Sex Differences in Atrial Fibrillation Catheter Ablation: Insights from a Prospective Multicenter Registry

真实世界数据:心房颤动导管消融术中的性别差异——来自前瞻性多中心注册研究的见解

2026-04-130
OA
The Impact of Vein of Marshall Alcohol or Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation Undergoing Catheter Ablation in the REAL-AF Registry

马歇尔静脉酒精或射频消融对接受导管消融治疗的持续性心房颤动患者的影响:REAL-AF注册研究

2026-03-060
OAAI
Real-world strategies for pulsed field ablation using a variable-loop circular catheter: a compendium of best practices from early adopters

使用可变环状导管进行脉冲场消融的实用策略:早期实践者的最佳实践汇编

2026-01-011
OAAI
Protocol for research examination of individual suicides occurring in chronic pain: A qualitative approach to psychological autopsy methodology (vol 20, e0329874, 2025)

慢性疼痛中个体自杀的研究调查方案:心理解剖方法学的定性研究方法(卷 20,e0329874,2025)

2025-12-260
OAAI
Protocol for research examination of individual suicides occurring in chronic pain: A qualitative approach to psychological autopsy methodology

个体慢性疼痛患者自杀案例的研究考察协议:心理解剖方法学的定性研究方法

2025-11-141
PRE
Low Acute Complication Rates with a Variable Loop Pulsed Field Ablation Catheter: Early Real-World Experience from the REAL-AF Registry

变量环脉冲场消融导管低急性并发症发生率:REAL-AF注册研究的早期真实世界经验

2025-10-170
OAAI
Real-world data analysis of trends in oral anticoagulation use in patients with atrial fibrillation following catheter ablation from a nationwide multicentric registry

全国多中心登记研究中房颤患者经导管消融术后口服抗凝药物使用趋势的真实世界数据分析

2025-02-210
PRE
High-frequency low-tidal volume ventilation improves procedural and long-term clinical outcomes in persistent atrial fibrillation ablation: Prospective multicenter registry

高频低潮气量通气可改善持续性心房颤动消融术中的操作及长期临床结局:前瞻性多中心登记研究

2025-02-012
PRE
Real-world data of radiofrequency catheter ablation in paroxysmal atrial fibrillation: Short- and long-term clinical outcomes from the prospective multicenter REAL-AF Registry

阵发性心房颤动射频导管消融术的真实世界数据: 前瞻性多中心Real-AF注册的短期和长期临床结果

2024-11-012
PRE